EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Self-reported racial and ethnic discrimination in patient-provider interactions and the initiation of adjuvant therapies for breast cancer in the pathways study

Kevin R Bitsie, Thomas A Pearson, Marilyn L Kwan, Lusine Yaghjyan, Lisa Scarton, Salma Shariff-Marco, Therese Y Andraos, Lia L D'Addario, Lawrence H Kushi, Ting-Yuan David Cheng iD

Breast Cancer Research and Treatment · 2026

DOI: 10.1007/s10549-026-08037-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Breast Cancer Research and Treatment, 2026. Verfasst von Kevin R Bitsie und 9 weiteren Autor:innen. Beteiligte Einrichtung: Dalla Lana School of Public Health, University of Toronto, 155 College St, 6th Floor, Toronto, ON, M5T3M7, Canada. kevin.bitsie@utoronto.ca. Hauptthemen laut MEDLINE: Breast Neoplasms, Healthcare Disparities, Physician-Patient Relations, Racism. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Northwest Native American Research Center for Health, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Despite advancements in breast cancer adjuvant therapies, some patients with indications may not receive treatment. We examined the association of self-reported racial/ethnic discrimination in patient-provider interactions and the receipt of clinically indicated therapies.

Methods

The Pathways Study is a prospective cohort of women diagnosed with invasive breast cancer from 2005 to 2013 at Kaiser Permanente Northern California. Racial/ethnic discrimination in patient-provider interactions was assessed from the Interpersonal Processes of Care survey at baseline, 6 months, and 24 months post-diagnosis. Logistic regression compared women who did not initiate clinically-indicated adjuvant therapy with those who did overall, and by race and ethnicity. Covariates included race and ethnicity, age at diagnosis, country of birth, education level, income, marital status, and American Joint Committee on Cancer staging.

Results

Overall, 3,610 women had indication for hormonal therapy, 2,450 for chemotherapy, and 3,258 for radiation therapy. In multivariable analyses, women reporting discrimination were at increased odds of not initiating hormonal therapy (adjusted odds ratio [aOR] = 1.43, 95% CI = 1.05–1.93) than those who did not self-report discrimination, regardless of their race/ethnicity. An increased odds of non-initiation for reported discrimination was found for radiation therapy (aOR = 1.26, 95% CI = 0.99–1.61), although it was not statistically significant. There was no association for chemotherapy initiation (aOR = 0.96, 95% CI = 0.69–1.33).

Conclusion

Self-reported racial/ethnic discrimination in patient-provider interactions was associated with the non-initiation of hormonal therapy in women with breast cancer. Further studies are needed to explore the impact of this association on breast cancer prognosis. Clinical trial registration Not applicable.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsHealthcare DisparitiesPhysician-Patient RelationsRacismAdultAgedFemaleHumansMiddle AgedChemotherapy, AdjuvantEthnicityProspective StudiesSelf ReportRacial Groups

Autor:innen und Institutionen

  • Dalla Lana School of Public Health, University of Toronto, 155 College St, 6th Floor, Toronto, ON, M5T3M7, Canada. kevin.bitsie@utoronto.ca.
  • Department of Epidemiology, University of Florida, Gainesville, FL, USA.
  • Division of Research, Kaiser Permanente Northern California, Pleasanton, CA, USA.
  • College of Nursing, University of Florida, Gainesville, FL, USA.
  • Department of Epidemiology and Biostatistics, School of Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.

ORCID-Profile: Ting-Yuan David Cheng

Förderung

  • Northwest Native American Research Center for Health
  • National Institutes of Health

Zitieren

APA

Bitsie, K. R., Pearson, T. A., Kwan, M. L., Yaghjyan, L., Scarton, L., Shariff-Marco, S., Andraos, T. Y., D'Addario, L. L., Kushi, L. H., & Cheng, T. D. (2026). Self-reported racial and ethnic discrimination in patient-provider interactions and the initiation of adjuvant therapies for breast cancer in the pathways study. Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-026-08037-w

Vancouver

Bitsie KR, Pearson TA, Kwan ML, Yaghjyan L, Scarton L, Shariff-Marco S, et al. Self-reported racial and ethnic discrimination in patient-provider interactions and the initiation of adjuvant therapies for breast cancer in the pathways study. Breast Cancer Research and Treatment. 2026. doi:10.1007/s10549-026-08037-w

BibTeX
@article{Bitsie2026,
  author = {Bitsie, Kevin R and Pearson, Thomas A and Kwan, Marilyn L and Yaghjyan, Lusine and Scarton, Lisa and Shariff-Marco, Salma and Andraos, Therese Y and D'Addario, Lia L and Kushi, Lawrence H and Cheng, Ting-Yuan David},
  title = {Self-reported racial and ethnic discrimination in patient-provider interactions and the initiation of adjuvant therapies for breast cancer in the pathways study},
  journal = {Breast Cancer Research and Treatment},
  year = {2026},
  doi = {10.1007/s10549-026-08037-w}
}
Kostenlos starten →